The four-strain seasonal influenza vaccine ‘Fluarix Tetra’ is approved for the first time in Korea
The Ministry of Food and Drug Safety approved sales of the GSK’s four-strain influenza vaccine ‘Fluarix Tetra’ for the first time in Korea. It is expected that its launch will be made in the second half of the next year and the drug will be available to vaccinate between 2015 and 2016.
As Green ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
